The traditional model, caloric restriction combined with increased physical activity, remains foundational, but it is increasingly recognized as insufficient on its own for individuals whose metabolic challenges are rooted in gut microbiome dysbiosis rather than simple energy imbalance
In general, the use of -glucosidase inhibitors is associated with mild weight loss, potentially due to their effects on nutrient absorption and appetite regulation
Its also necessary for the formation of red blood cells, which help supply the cells with oxygen so they can function properly
The lead author of the 2025 narrative review titled "Regeneration or Risk?" emphasized the urgent need for randomized controlled trials
Shagroni T et al (2021): Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Nonopioid Analgesics, & Drugs Used in Gout (Chapter 36)